District of Columbia

California

The Board of Pharmacy posted a agenda for the Enforcement and Compounding Committee meeting on March 27. Please note the discussion and consideration of implementation of AB 1902 (Chapter 330, Statutes of 2024) related to prescription drug labels: accessibility.

Also in California, the Board of Pharmacy has proposed additional modifications to Title 16 CCR § 1708.2, related to the Discontinuance of Business.

Any person who wishes to comment on the proposed additional modifications may do so by submitting written comments beginning on March 11 and ending on March 26 to the following:

Contact Person: Lori Martinez

Agency Name: California State Board of Pharmacy

Address: 2720 Gateway Oaks Drive, Ste 100, Sacramento, CA 95833

Email: PharmacyRulemaking@dca.ca.gov

Fax: 916-574-8618

Any responses to comments directly concerning the proposed modifications to the text of the regulations will be considered and responded to in the Final Statement of Reasons.

Also in California, the Board of Pharmacy extends its sincere appreciation to its licensees for assisting the survivors of the Los Angeles Fires. Your commitment to California consumers is commendable. The Board has received notification that the Emergency Prescription Assistance Program (EPAP) ended on March 15. Once the EPAP activation ended, the vendor stopped processing further prescription claims for individuals in the designated Los Angeles zip codes.

Also in California, the Department of Health Care Service posted the following weekly notice on the Medi-Cal Rx Web Portal: Medi-Cal Rx Weekly Wrap-up for March 7-13.

Finally in California, the Department of Health Care Services posted the following:

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2025-03-20T15:58:27-04:00March 20, 2025|Alabama, Alaska, California, District of Columbia, Georgia, Massachusetts, Montana, Oregon, South Carolina, Tennessee, Vermont|

District of Columbia

The Department of Health Care Finance (DCHF) published a final rule permitting billing for MTM services. The rule was effective February 24, 2025.

Also, in the District of Columbia, the DCHF is hosting the next Pharmacy Provider Forum on March 18 and 19. The content is identical for both sessions. The invitation provides more detail and information to RSVP no later than March 17.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2025-03-13T15:56:00-04:00March 13, 2025|District of Columbia|

District of Columbia

The Department of Health Care Finance (DHCF) Quarterly Pharmacy Stakeholders meeting will take place on December 19 and 20. A virtual meeting link is available by RSVP’ing to allison.williams@primetherapeutics.com no later than December 18.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2023-12-08T10:06:48-05:00December 8, 2023|District of Columbia|

District of Columbia

The Board of Pharmacy’s June newsletter has been published.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2023-06-09T10:22:42-04:00June 9, 2023|District of Columbia|

District of Columbia

DCHF announced they will hold their quarterly pharmacy forum meeting on September 20 at 10am and September 21 at 1pm. To register to attend and receive meeting link and agenda please contact Amwilliams1@magellanhealth.com.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2022-09-16T09:54:22-04:00September 16, 2022|District of Columbia|

District of Columbia

Medicaid has scheduled the virtual quarterly pharmacy forum on March 15 from 1-2pm and March 16 from 10-11:30 pm and are “highly encouraging” attendance. Click here to RSVP and receive the log in information.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2022-02-25T11:46:03-05:00February 25, 2022|District of Columbia|

District of Columbia

NACDS received an email from Pharmacy Services stating that “effective January 15, 2022, the Department of Health Care Finance (DHCF) is covering FDA-approved COVID-19 Home test kit(s) dispensed by pharmacies enrolled with DC Medicaid. Pharmacies must submit claims through the Fee-for-Service (FFS) Medicaid Pharmacy Benefit Manager to receive reimbursement from DHCF for HSCSN enrollee(s). HSCSN enrollees are eligible for test kits through the DC Medicaid Fee-For-Service program with no co-payment. Feel free to contact the DHCF Division of Clinician, Pharmacy, and Acute Provider Services:

Charlene Fairfax, Senior Pharmacist at (202) 442-9076, charlene.fairfax@dc.gov

Gidey Amare, Pharmacist at (202) 442-5952, gidey.amare@dc.gov

Jonas Terry, Pharmacist at (202) 478-1415, jonas.terry@dc.gov

Magellan (Pharmacy Benefit Manager) at 1-800-273-4962″

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2022-02-11T11:58:34-05:00February 11, 2022|District of Columbia|

District of Columbia

The Department of Health approved a final rule requiring reporting of vaccines by all providers, including pharmacies, with 24 hours of vaccine administration to the registry. The rule will be effective when published in the DC Register.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-12-10T12:12:27-05:00December 10, 2021|District of Columbia|

District of Columbia

The latest edition of the Board of Pharmacy’s newsletter is available here. It contains updated board contact information, the schedule of meetings, links to the new online licensing portal and a reminder about the Opioid Labeling Act which was effective in March of 2021.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-11-05T10:49:02-04:00November 5, 2021|District of Columbia|